Ayurveda · Classical Ayurveda (Sanskrit medical tradition; living practice in India and diaspora)

Rejuvenate with rasāyana: ashwagandha

Caraka Saṃhitā Ci. 1 (rasāyana); aśvagandhā in Caraka Sū. 4 nourishing/strength groups (locator not independently checked)

What the tradition teaches

What the tradition teaches

Rasāyana therapy aims at long life, memory, intelligence, freedom from disease, youthfulness and strength [1]. Aśvagandhā (Withania somnifera) root is a classic strength-promoting and rejuvenating herb, now one of the world’s best-selling supplements.

Historical context

What the tradition teaches

Classical rasāyana was given after purification and with a strict regimen; modern use is mostly standardised root (sometimes leaf) extracts sold as ‘adaptogens’.

Original meaning and purpose

What the tradition teaches

Rasāyana nourishes the tissues and ojas — building resilience rather than treating a disease.

How Eternal Light interprets it

How Eternal Light interprets it

Eternal Light reads rasāyana as the hope of replenishing a person’s light through partnership with a plant. The plant gives; the receiver should take only what is needed, from sustainable sources, and with honest attention to harms. A herb that eases stress for some and injures the liver of a few is a genuinely mixed gift.

Observable mechanism

What research supports

Testable claim: ashwagandha extract reduces perceived stress and improves sleep compared with placebo, with acceptable safety.

What the research shows

What research supports

Meta-analyses of small RCTs show benefits: sleep SMD −0.59 (5 RCTs, 400 adults) [2]; Perceived Stress Scale MD −4.72 and lower cortisol (9 RCTs, 558 people) [3]. A 2025 meta-analysis found lower cortisol but no significant effect on perceived stress [4]. Trials are short, often industry-linked and use differing extracts. NCCIH: may help stress and insomnia short-term; long-term safety unknown [5]. Certainty: low-to-moderate for short-term benefit.

Exceptions, conflicts, and open questions

Safety. Liver injury is rare but documented: cholestatic hepatitis after 2–12 weeks [6]; in an Indian series three patients with pre-existing liver disease died of acute-on-chronic liver failure [7]; LiverTox rates it a probable rare cause [8]. Avoid in pregnancy and breastfeeding; caution with thyroid disease, autoimmune disease, hormone-sensitive prostate cancer, and with sedatives, thyroid, diabetes, blood-pressure, anti-seizure and immunosuppressant drugs [5]. Denmark banned ashwagandha in food supplements in 2023 after a 2020 risk assessment [9]; that assessment is disputed by pharmacognosists [10].

Who gains or loses light

How Eternal Light interprets it

Eternal Light’s reading (a metaphysical interpretation, not an observed measurement)
ParticipantEffectWhy
The actor (self) mixedModest stress/sleep benefits; rare serious liver injury
Plants mixedGlobal demand pressure on cultivation

Sources cited

  1. Charak Samhita Research, Training and Development Centre (Jamnagar), editors. Charak Samhita Online: Caraka Saṃhitā, Sanskrit text with English translation and commentary (2020–)
  2. Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis (2021)
  3. Arumugam V, Vijayakumar V, Balakrishnan A, et al.. Effects of Ashwagandha (Withania somnifera) on stress and anxiety: A systematic review and meta-analysis (2024)
  4. Albalawi AA. Dual impact of Ashwagandha: Significant cortisol reduction but no effects on perceived stress — A systematic review and meta-analysis (2025)
  5. National Center for Complementary and Integrative Health (NIH). Ashwagandha: Usefulness and Safety (2023)
  6. Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, Hayashi PH, Navarro V. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network (2020)
  7. Philips CA, Valsan A, Theruvath AH, et al. (Liver Research Club India). Ashwagandha-induced liver injury — A case series from India and literature review (2023)
  8. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Ashwagandha (2012– (continuously updated))
  9. DTU Fødevareinstituttet (National Food Institute, Technical University of Denmark) for Fødevarestyrelsen. Risikovurdering af Withania somnifera (ashwagandha) [Risk assessment of Withania somnifera] (2020)
  10. Chittiboyina AG, Khan IA. Current issues in phytomedicine research — Conundrum on the chemistry of ashwagandha and its biological effects (2024)

Related teachings